JP2019518439A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019518439A5 JP2019518439A5 JP2018557329A JP2018557329A JP2019518439A5 JP 2019518439 A5 JP2019518439 A5 JP 2019518439A5 JP 2018557329 A JP2018557329 A JP 2018557329A JP 2018557329 A JP2018557329 A JP 2018557329A JP 2019518439 A5 JP2019518439 A5 JP 2019518439A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- meg3
- cardiac
- acid sequence
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16167961 | 2016-05-02 | ||
| EP16167961.8 | 2016-05-02 | ||
| PCT/EP2017/059984 WO2017191021A1 (en) | 2016-05-02 | 2017-04-26 | The incrna meg3 for therapy and diagnosis of cardiac remodelling |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019518439A JP2019518439A (ja) | 2019-07-04 |
| JP2019518439A5 true JP2019518439A5 (https=) | 2020-05-07 |
| JP6928001B2 JP6928001B2 (ja) | 2021-09-01 |
Family
ID=56026647
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018557329A Active JP6928001B2 (ja) | 2016-05-02 | 2017-04-26 | 心臓リモデリングの治療及び診断のためのlncRNA Meg3 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US11186838B2 (https=) |
| EP (1) | EP3452593B1 (https=) |
| JP (1) | JP6928001B2 (https=) |
| WO (1) | WO2017191021A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3102271A1 (en) * | 2018-06-01 | 2019-12-05 | Children's National Medical Center | Compositions and methods for treating and preventing muscular disorders and dystrophies, steroid side effects, and inflammation |
| EP4547841A1 (en) * | 2022-06-30 | 2025-05-07 | Medizinische Hochschule Hannover | Long non-coding rnas as target for treating fibrosis and cancer |
| CN116179545B (zh) * | 2022-09-09 | 2025-10-31 | 上海工程技术大学 | LncRNA Gm20257在制备防治病理性心肌肥厚药物中的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9416422B2 (en) * | 2005-02-18 | 2016-08-16 | Sloan-Kettering Institute For Cancer Research | Methods for detecting minimum residual disease |
| WO2007097741A1 (en) | 2006-02-17 | 2007-08-30 | The Trustees Of Columbia University In The City Of New York | Method of diagnosing intrauterine growth restriction |
| JP5936131B2 (ja) * | 2010-01-15 | 2016-06-15 | 国立大学法人京都大学 | 人工多能性幹細胞の選別方法 |
| US9920317B2 (en) * | 2010-11-12 | 2018-03-20 | The General Hospital Corporation | Polycomb-associated non-coding RNAs |
-
2017
- 2017-04-26 EP EP17722704.8A patent/EP3452593B1/en active Active
- 2017-04-26 JP JP2018557329A patent/JP6928001B2/ja active Active
- 2017-04-26 US US16/098,793 patent/US11186838B2/en active Active
- 2017-04-26 WO PCT/EP2017/059984 patent/WO2017191021A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017514813A5 (https=) | ||
| US11981895B2 (en) | Hippo and dystrophin complex signaling in cardiomyocyte renewal | |
| JP6805304B2 (ja) | 心肥大の治療および診断のためのlncRNA | |
| KR20140074997A (ko) | 신경병성 질환에서 마이크로rna | |
| Sangaralingham et al. | Cardiorenal fibrosis and dysfunction in aging: imbalance in mediators and regulators of collagen | |
| van der Pouw Kraan et al. | Systemic toll-like receptor and interleukin-18 pathway activation in patients with acute ST elevation myocardial infarction | |
| JP2002501366A (ja) | 心筋不全の診断と治療 | |
| Haddad et al. | Regulation of antisense RNA expression during cardiac MHC gene switching in response to pressure overload | |
| JP2018518147A5 (https=) | ||
| JP2019518439A5 (https=) | ||
| JP2018504909A5 (https=) | ||
| JP2020502498A5 (https=) | ||
| US11761966B2 (en) | Nourin gene-based RNA molecular network: novel early diagnostic and prognostic biomarkers for coronary artery disease, unstable angina, STEMI/NSTEMI and heart failure | |
| KR20150131555A (ko) | 근육노화 진단 및 치료를 위한 마이크로rna-136 | |
| CN112691193B (zh) | 用于治疗扩张型心肌病的药物及筛选方法及用途 | |
| WO2014195693A1 (en) | Prevention and treatment of atrial fibrillation | |
| Chi et al. | Nuclear factor 45 of tongue sole (Cynoglossus semilaevis): evidence for functional differentiation between two isoforms in immune defense against viral and bacterial pathogens | |
| Thomas et al. | Epigenetics: Its Role in Aging, Diseases and Biological Age Estimation | |
| 김명진 et al. | Early Effect of (-)-epigallocatechin-3-gallate (EGCG) on Phosphorylation of Akt | |
| Qin et al. | MicroRNA-214 Inhibits Cardiac Remodeling in Mouse Models of Cardiac Pressure Overload | |
| CN117305431A (zh) | lncRNA NONMMUT067673.2作为生物标志物在用于制备慢性心力衰竭和心肌纤维化检测试剂或抑制剂中的应用 | |
| Moles et al. | The Relationship Between Brain–Heart Autonomic Signaling and Aging: A Gender-Specific Longitudinal Perspective from the Baltimore Longitudinal Study on Aging | |
| KR20150131557A (ko) | 근육노화 진단 및 치료를 위한 마이크로rna-127 | |
| KR20150131559A (ko) | 근육노화 진단 및 치료를 위한 마이크로rna-34 |